Literature DB >> 2207591

Differing effects of pethidine and morphine on human sphincter of Oddi motility.

A Thune1, R A Baker, G T Saccone, H Owen, J Toouli.   

Abstract

The aim of this study was to evaluate the effects of morphine and pethidine on human sphincter of Oddi motility. The action of these opioids on the sphincter of Oddi was evaluated by means of intraoperative manometry in 36 patients undergoing elective cholecystectomy. Both opioids were given in intravenous cumulative equipotent doses up to a maximum of 10 micrograms/kg morphine or 100 micrograms/kg pethidine. At these doses, morphine increased the mean(s.d.) frequency of contractions from 2.4(1.0) to 7.9(1.6) (P less than 0.001); this effect was reduced by naloxone (0.04 mg bolus, P less than 0.05). Pethidine inhibited the frequency of contractions from 1.5(0.8) to 0.8(0.5) (P less than 0.05); this response was blocked by atropine (0.6 mg bolus, P less than 0.01). Pretreatment with atropine or naloxone reduced the frequency of contractions significantly (P less than 0.05). The results illustrate different responses to pethidine and morphine of the sphincter of Oddi, and provide a pharmacological explanation for the suitability of pethidine over morphine as the analgesic of choice in patients experiencing biliary pain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207591     DOI: 10.1002/bjs.1800770911

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

Review 1.  Bile leaks from the duct of Luschka (subvesical duct): a review.

Authors:  Constantine P Spanos; Theodore Syrakos
Journal:  Langenbecks Arch Surg       Date:  2006-08-23       Impact factor: 3.445

2.  Pharmacological management of chronic pain: a clinician's perspective.

Authors:  D A Cherry; G K Gourlay
Journal:  Agents Actions       Date:  1994-10

3.  Effects of narcotic analgesic drugs on human Oddi's sphincter motility.

Authors:  Shuo-Dong Wu; Zhen-Hai Zhang; Jun-Zhe Jin; Jing Kong; Wei Wang; Qiang Zhang; Dong-Yan Li; Min-Fei Wang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

4.  Effects of botulinum toxin A on the sphincter of Oddi: an in vivo and in vitro study.

Authors:  J Sand; I Nordback; P Arvola; I Pörsti; A Kalloo; P Pasricha
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

Review 5.  Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.

Authors:  C H Wilder-Smith
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

6.  Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction.

Authors:  P J Pasricha; E P Miskovsky; A N Kalloo
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 7.  Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.

Authors:  Stefan Müller-Lissner; Gabrio Bassotti; Benoit Coffin; Asbjørn Mohr Drewes; Harald Breivik; Elon Eisenberg; Anton Emmanuel; Françoise Laroche; Winfried Meissner; Bart Morlion
Journal:  Pain Med       Date:  2017-10-01       Impact factor: 3.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.